Western blot and immunohistochemistry analyses have revealed that HCC derived from mifepristone‐treated KRAS transgenic zebrafish show activation of Ras/ERK and PI3K/Akt signaling pathways, and these active states are dramatically decreased after the withdrawal of mifepristone. The gene discussed is KRAS; the disease is hepatocellular carcinoma.